IP Library Granted Patent US 11,701,016
Granted Patent B2
US 11,701,016 · App. 16/872,321 · Granted Jul 18, 2023

Facilitating assessment of blood flow and tissue perfusion using fluorescence-mediated photoplethysmography

Inventors: Robert W. Flower (Hunt Valley, MD); Robert Anthony Stead (Vancouver, CA); Arthur E. Bailey (North Vancouver, CA)
Assignee: Stryker European Operations Limited
A61B5/0261A61B5/0071A61B5/029A61B5/0275A61B5/02416A61B5/6826
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,701,016
App. No.
16/872,321
Granted
Jul 18, 2023
Kind
B2
Abstract

Methods and systems for facilitating assessment of blood flow in a tissue volume of a subject are disclosed. In some variations, the method may include: after a predetermined amount of a fluorescence agent has been administered to the subject, exciting the fluorescence agent in the tissue volume such that the excited fluorescence agent emits fluorescent light, acquiring fluorescence data based on the fluorescent light emitted during blood flow through the tissue volume, estimating a molar concentration of the fluorescence agent in the blood flowing through the tissue volume, and generating an assessment of blood flow in the tissue volume based at least in part on the fluorescence data and the estimated molar concentration of the fluorescence agent. The estimated molar concentration may be based on the predetermined amount of the fluorescence agent and an estimated circulating blood volume of the subject.

Claims (44)

1. A method for use in medical imaging for facilitating assessment of microvascular tissue perfusion in a tissue volume of a subject, the method comprising:

after a predetermined amount of a fluorescence agent has been administered to the subject, exciting the fluorescence agent in the tissue volume such that the excited fluorescence agent emits fluorescent light;

acquiring fluorescence image data based on the fluorescent light emitted during blood flow through the tissue volume;

processing the fluorescence image data to compensate for ambient light;

processing the fluorescence image data by suppressing image data corresponding to non-microvascular blood vessels; and

generating an assessment of microvascular tissue perfusion in the tissue volume based at least in part on the processed fluorescence image data.

2. The method of claim 1 , wherein:

the method further comprises determining a molar concentration of the fluorescence agent in the blood flowing through the tissue volume; and

generating the assessment of microvascular tissue perfusion in the tissue volume is based at least in part on the molar concentration.

3. The method of claim 2 , wherein determining the molar concentration comprises estimating the molar concentration.

4. The method of claim 3 , wherein estimating the molar concentration comprises estimating a circulating blood volume in the subject.

5. The method of claim 4 , wherein estimating the circulating blood volume in the subject is based at least in part on one or more of sex, body height, and body weight of the subject.

6. The method of claim 2 , wherein determining the molar concentration comprises calculating the molar concentration.

7. The method of claim 6 , wherein calculating the molar concentration is based at least in part on a spectral shift in a fluorescence emission spectrum of the fluorescence agent.

8. The method of claim 1 , wherein generating the assessment of microvascular tissue perfusion in the tissue volume is based at least in part on one or more of a cross-sectional area of the tissue volume, a thickness increase of a blood volume layer, a pulse duty cycle of blood flow, and duration of a single pressure pulse in blood flow.

9. The method of claim 1 , wherein generating an assessment of microvascular tissue perfusion is based at least in part on an intensity of the fluorescence image data during a diastolic phase of blood flow and an intensity of the fluorescence image data during a systolic phase of the blood flow.

10. The method of claim 1 , wherein the tissue volume is selected in the fluorescence image data by a user.

11. The method of claim 1 , wherein the fluorescence agent comprises indocyanine green.

12. A system for facilitating assessment of microvascular tissue perfusion in a tissue volume of a subject, the system comprising:

a light source configured to excite a fluorescence agent in the tissue volume, after a predetermined amount of the fluorescence agent has been administered to the subject, such that the fluorescence agent emits fluorescent light;

one or more processors; and

memory having instructions stored thereon, wherein the instructions, when executed by the one or more processors, cause the system to:

receive fluorescence data based on the fluorescent light emitted from the excited fluorescence agent in the tissue volume;

process the fluorescence image data to compensate for ambient light;

process the fluorescence image data by suppressing image data corresponding to non-microvascular blood vessels; and

generate an assessment of microvascular tissue perfusion in the tissue volume based at least in part on the processed fluorescence image data and the determined concentration of the fluorescence agent.

13. A non-transitory computer-readable storage medium storing instructions for facilitating assessment of microvascular tissue perfusion in a tissue volume of a subject, wherein the instructions, when executed by a system comprising a light source and one or more processors, cause a system to:

excite, by the light source, a fluorescence agent in the tissue volume, after a predetermined amount of the fluorescence agent has been administered to the subject, such that the fluorescence agent emits fluorescent light;

receive fluorescence image data based on the fluorescent light emitted during blood flow through the tissue volume;

process the fluorescence image data to compensate for ambient light;

process the fluorescence image data by suppressing image data corresponding to non-microvascular blood vessels; and

generate an assessment of microvascular tissue perfusion in the tissue volume based at least in part on the processed fluorescence image data and the determined concentration of the fluorescence agent.

14. The system of claim 12 , wherein:

the method further comprises determining a molar concentration of the fluorescence agent in the blood flowing through the tissue volume; and

generating the assessment of microvascular tissue perfusion in the tissue volume is based at least in part on the molar concentration.

15. The system of claim 14 , wherein determining the molar concentration comprises estimating the molar concentration.

16. The system of claim 15 , wherein estimating the molar concentration comprises estimating a circulating blood volume in the subject.

17. The system of claim 16 , wherein estimating the circulating blood volume in the subject is based at least in part on one or more of sex, body height, and body weight of the subject.

18. The system of claim 14 , wherein determining the molar concentration comprises calculating the molar concentration.

19. The system of claim 18 , wherein calculating the molar concentration is based at least in part on a spectral shift in a fluorescence emission spectrum of the fluorescence agent.

20. The system of claim 12 , wherein generating the assessment of microvascular tissue perfusion in the tissue volume is based at least in part on one or more of a cross-sectional area of the tissue volume, a thickness increase of a blood volume layer, a pulse duty cycle of blood flow, and duration of a single pressure pulse in blood flow.

21. The system of claim 12 , wherein generating an assessment of microvascular tissue perfusion is based at least in part on an intensity of the fluorescence image data during a diastolic phase of blood flow and an intensity of the fluorescence image data during a systolic phase of the blood flow.

22. The system of claim 12 , wherein the tissue volume is selected in the fluorescence image data by a user.

23. The system of claim 12 , wherein the fluorescence agent comprises indocyanine green.

Assignments (8)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 26, 2023
From: STRYKER EUROPEAN OPERATIONS LIMITED
To: STRYKER CORPORATION
Reel/Frame 066140/0647 →
NUNC PRO TUNC ASSIGNMENT Recorded Jul 23, 2021
From: STRYKER EUROPEAN HOLDINGS I, LLC
To: STRYKER EUROPEAN HOLDINGS IV, LLC
Reel/Frame 056963/0234 →
NUNC PRO TUNC ASSIGNMENT Recorded Jul 23, 2021
From: STRYKER EUROPEAN HOLDINGS IV, LLC
To: STRYKER EUROPEAN HOLDINGS III, LLC
Reel/Frame 056963/0375 →
NUNC PRO TUNC ASSIGNMENT Recorded Jul 23, 2021
From: STRYKER EUROPEAN HOLDINGS III, LLC
To: STRYKER EUROPEAN HOLDINGS LLC
Reel/Frame 056963/0672 →
NUNC PRO TUNC ASSIGNMENT Recorded Jul 23, 2021
From: NOVADAQ TECHNOLOGIES ULC
To: STRYKER EUROPEAN HOLDINGS I, LLC
Reel/Frame 056963/0101 →
NUNC PRO TUNC ASSIGNMENT Recorded Jul 23, 2021
From: STRYKER EUROPEAN HOLDINGS LLC
To: STRYKER EUROPEAN OPERATIONS LIMITED
Reel/Frame 056963/0905 →
MERGER AND CHANGE OF NAME Recorded Jan 15, 2021
From: NOVADAQ TECHNOLOGIES INC.; STRYKER CANADA OPERATIONS ULC
To: NOVADAQ TECHNOLOGIES ULC
Reel/Frame 055012/0220 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 13, 2021
From: FLOWER, ROBERT W.; STEAD, ROBERT ANTHONY; BAILEY, ARTHUR E.
To: NOVADAQ TECHNOLOGIES INC.
Reel/Frame 054911/0297 →
Cited By (1)
US 12,465,229